The weakness in the stock was because of inspections by the American drug regulator at its Halol plant in Gujarat which resulted in eight observations, as well as a downward revision of speciality......
AstraZeneca has filed a lawsuit against Indian major Ranbaxy Laboratories in the district court of New Jersey, US, alleging "wilful infringement" of its patent for esomeprazole magnesium, marketed......
Markets scaled higher on the last day of December derivatives series due to strength in energy and index heavyweight shares such as HDFC and Infosys. The S&P BSE Sensex ended higher 158 points at......
Ranbaxy Laboratories on Wednesday reported widening of its consolidated net loss to Rs 1,029.72 crore (Rs 10.29 billion) for the third quarter ended December 31, 2014, as higher costs and foreign......
The Ranbaxy brand might be gradually phased out in the near future in the wake of this year’s largest merger in the Asian pharma sector. After Monday’s conditional nod from the......